Skip to main navigation
Close

Here for you, every second

Locations

  • United Kingdom 
    Kiniksa Pharmaceuticals
    International, plc
    Kiniksa Pharmaceuticals (UK), Ltd.
    Second Floor
    105 Piccadilly
    London, UK
    W1J 7NJ
  • USA Headquarters
    Kiniksa Pharmaceuticals Corp.
    100 Hayden Avenue
    Lexington, MA 02421 USA
    (781) 431-9100
  • Switzerland
    Kiniksa Pharmaceuticals, GmbH
    Grafenaustrasse 5
    6300 Zug, Switzerland
  • USA California
    Kiniksa Pharmaceuticals Corp.
    3366 N. Torrey Pines Court
    #320
    La Jolla, CA 92037

Utility

  • Contact Us
Home

Main navigation

  • About Us
    • Leadership
    • Partnerships
    • Compliance & Ethics
    • Grants & Giving
  • Medicines & Pipeline
    • Medicine
    • Pipeline
    • Disease Registries
    • Treatment Access
  • Patients & Advocacy
    • Our Disease Areas
    • Patient Advocacy
    • Stay Informed
  • Investors
  • For Healthcare Professionals
    • Congress Materials
    • Manuscript Publications
    • Medical Information Resources
  • Join Us
Menu

IR navigation

  • News & Events
    • Press Releases
    • Events and Presentations
    • Articles
  • Stock Information
    • Stock Quote & Chart
    • Historical Price Lookup
  • Financial Information
    • SEC Filings
    • Annual Reports & Proxy Statement
    • Tax Information
  • Corporate Governance
    • Documents & Charters
    • Board of Directors
    • Management
    • Committee Composition
  • Investor Resources
    • Investor FAQs
    • Investor Contacts
    • Email Alerts

Articles

  • 04/21/25

    KNSA_ARS_Web_Posting_Proof.pdf 6.3 MB

  • 05/10/24

    2023 Annual Report 4.7 MB

  • 06/14/23

    2022 Annual Report 7.1 MB

  • 06/27/22

    2021 Annual Report 3.4 MB

  • 04/28/21

    2020 Annual Report 2.5 MB

  • 04/17/19

    2019 Proxy Statement 147.9 KB

  • 04/17/19

    2018 Annual Report 4.7 MB

  • 05/25/18

    BioWorld: Pair of pricings, IPO filing keep public markets busy for biopharma 59.4 KB

  • 01/13/17

    BioWorld: Kiniksa makes JPM debut; discloses $80M series A, first asset 72.8 KB

  • 08/31/16

    BioWorld: Together again: Former Synageva execs return with startup Kiniksa 56 KB

Print Page
RSS
Email Alerts
Search
Image
KINIKSA Pharmaceuticals
  • United Kingdom 
    Kiniksa Pharmaceuticals
    International, plc
    Kiniksa Pharmaceuticals (UK), Ltd.
    Second Floor
    105 Piccadilly
    London, UK
    W1J 7NJ
  • USA Headquarters
    Kiniksa Pharmaceuticals Corp.
    100 Hayden Avenue
    Lexington, MA 02421 USA
    (781) 431-9100
  • Switzerland
    Kiniksa Pharmaceuticals, GmbH
    Grafenaustrasse 5
    6300 Zug, Switzerland
  • USA California
    Kiniksa Pharmaceuticals Corp.
    3366 N. Torrey Pines Court
    #320
    La Jolla, CA 92037
Copyright © 2026 Kiniksa Pharmaceuticals
All Rights Reserved. All trademarks mentioned are the property of their respective owners.
Terms of Use | Privacy Policy | Accessibility Statement
|Cookie Policy | Cookie Settings